June 8, 2022 — Proscia, a leader in digital and computational pathology solutions, announced that its Concentriq Dx platform has been certified under the new
June 8, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced completion of patient accrual in its Phase 3 REVELATE clinical trial of 18F-fluciclovine, a
June 7, 2022 — Laurel Bridge Software, Inc., a provider of imaging software solutions that enables health systems to orchestrate their complex medical imaging workflows, announces the following new capabilities that are planned for 2022:
June 3, 2022 — Henry Ford Health is the first in the world to complete a full course of patient treatments using the latest advancement in magnetic resonance (MR)-guided radiation therapy, which integrates real-time magnetic resonance imaging (MRI) and linear acceleration to deliver precise and accurate radiation treatment more rapidly than ever before.
